| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales and other operating revenues: | $30.15B-9.7% | $33.39B+0.2% | $33.34B-33.9% | $50.45B | ||||||||||||||
| Sales and other operating revenues: | $30.15B-9.7% | $33.39B+0.2% | $33.34B-33.9% | $50.45B | ||||||||||||||
| Operating costs and expenses: | — | — | — | — | ||||||||||||||
| Cost of sales | $27.58B-4.1% | $28.75B+1.1% | $28.43B-35.1% | $43.85B | ||||||||||||||
| Goodwill impairments | $972.0M | $0-100.0% | $252.0M | — | ||||||||||||||
| Other impairments | $279.0M-70.6% | $949.0M+272.2% | $255.0M | — | ||||||||||||||
| Selling, general and administrative expenses | $1.61B-1.9% | $1.64B+6.7% | $1.54B+17.5% | $1.31B | ||||||||||||||
| Research and development expenses | $136.0M+0.7% | $135.0M+3.8% | $130.0M+4.8% | $124.0M | ||||||||||||||
| Operating costs and expenses | $30.57B-2.9% | $31.48B+2.8% | $30.61B-32.5% | $45.35B | ||||||||||||||
| Operating income (loss) | -$420.0M-121.9% | $1.92B-29.6% | $2.73B-46.6% | $5.10B | ||||||||||||||
| Interest expense | -$487.0M-1.2% | -$481.0M-0.8% | -$477.0M-66.2% | -$287.0M | ||||||||||||||
| Interest income | $97.0M-35.3% | $150.0M+16.3% | $129.0M+344.8% | $29.0M | ||||||||||||||
| Gain (loss) on sale of business | -$6.0M-102.1% | $284.0M | $0 | $0 | ||||||||||||||
| Other income (expense), net | $113.0M+140.4% | $47.0M+181.0% | -$58.0M+19.4% | -$72.0M | ||||||||||||||
| Income (loss) from continuing operations before equity investments and income taxes | -$703.0M-136.7% | $1.92B-17.3% | $2.32B-51.4% | $4.77B | ||||||||||||||
| Loss from equity investments | -$12.0M+94.5% | -$217.0M-985.0% | -$20.0M-500.0% | $5.0M | ||||||||||||||
| Income (loss) from continuing operations before income taxes | -$715.0M-142.0% | $1.70B-26.0% | $2.30B-51.9% | $4.78B | ||||||||||||||
| Provision for income taxes | $70.0M-73.0% | $259.0M-40.2% | $433.0M-50.9% | $882.0M | ||||||||||||||
| Income (loss) from continuing operations | -$785.0M-154.4% | $1.44B-22.7% | $1.87B-52.1% | $3.89B | ||||||||||||||
| Income (loss) from discontinued operations, net of tax | $47.0M+162.7% | -$75.0M-129.4% | $255.0M+5200.0% | -$5.0M | ||||||||||||||
| Net (loss) income | -$738.0M-154.0% | $1.37B-35.5% | $2.12B-45.5% | $3.89B | ||||||||||||||
| Dividends on redeemable non-controlling interests | -$7.0M+0.0% | -$7.0M+0.0% | -$7.0M+0.0% | -$7.0M | ||||||||||||||
| Net income (loss) attributable to the Company shareholders | -$745.0M-154.8% | $1.36B-35.7% | $2.11B-45.5% | $3.88B | ||||||||||||||
| Continuing operations (in dollars per share) | -$2480000.00-156.4% | $4400000.00-22.8% | $5700000.00-51.9% | $11860000.00 | ||||||||||||||
| Discontinued operations (in dollars per share) | $140000.00+158.3% | -$240000.00-130.8% | $780000.00+4000.0% | -$20000.00 | ||||||||||||||
| Basic (in dollars in per share) | -$2340000.00-156.3% | $4160000.00-35.8% | $6480000.00-45.3% | $11840000.00 | ||||||||||||||
| Continuing operations (in dollars per share) | -$2480000.00-156.5% | $4390000.00-22.7% | $5680000.00-52.0% | $11830000.00 | ||||||||||||||
| Discontinued operations (in dollars per share) | $140000.00+158.3% | -$240000.00-130.8% | $780000.00+4000.0% | -$20000.00 | ||||||||||||||
| Diluted (in dollars per share) | -$2340000.00-156.4% | $4150000.00-35.8% | $6460000.00-45.3% | $11810000.00 | ||||||||||||||
| Trade | ||||||||||||||||||
| Related parties | ||||||||||||||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.